Using interrupted time-series analysis and National Health Insurance data between January 2000 and August 2003, this study assessed the impacts of the severe acute respiratory syndrome (SARS) epidemic on medical service utilization in Taiwan. At the peak of the SARS epidemic, significant reductions in ambulatory care (23.9%), inpatient care (35.2%), and dental care (16.7%) were observed. People’s fears of SARS appear to have had strong impacts on access to care. Adverse health outcomes resulting from accessibility barriers posed by the fear of SARS should not be overlooked.

Since the outbreak of severe acute respiratory syndrome (SARS), its etiology, transmission routes, treatments, and outcomes have received much research attention.1–5 SARS has low mortality and morbidity; however, the health consequences of the SARS epidemic are not limited to people who have been infected.6 The potentially serious impact of SARS on people’s accessibility to medical services should not be overlooked.7–10 However, no study has systematically evaluated the impact of the fear of SARS on the general population.

People’s fears of SARS were mainly caused by its novel, rapid nosocomial transmission, and the vulnerability of hospitals and health care workers. Many wondered whether the fears of SARS among patients and health care workers alike deterred people from seeking care or providers from offering services. Therefore, a critical challenge is to determine how public health agencies should respond to utilization changes and possible accessibility barriers to the general population created by the SARS epidemic. In this study, we aimed to assess how people’s fears of SARS influenced their utilization patterns of medical services in Taiwan.

The SARS epidemic in Taiwan started in mid-March 2003 and lasted for almost 4 months. The epidemic was effectively contained during the initial SARS period (March 14 to April 21, 2003).11 However, multiple clusters of hospital outbreaks among patients and health care workers initially struck at the end of April and extended to May and June, dramatically exacerbating the epidemic. As a result, overwhelming fears of SARS spread over the entire island along with the SARS epidemic. The situation persisted until July 5, when Taiwan was officially removed from the World Health Organization’s list of SARS-affected countries.11,12

We retrieved all claims made to the National Health Insurance program between January 1, 2000, and August 31, 2003, including inpatient care, Western medicine ambulatory care, Chinese medicine services, and dental services. An interrupted time-series design was used. Trends for different types of services were analyzed separately to determine whether utilization changes were specific to certain services. The time-series autoregressive-moving average (ARIMA) analysis13 was applied to determine whether the SARS epidemic was significantly associated with changes in medical service utilization rates. Relative differences between observed and ARIMA-predicted values were expressed in percentages. All analyses were performed using SAS for Windows, Version 8.2 (SAS Institute Inc, Cary, NC) and Stata 8.0 (Stata Corp, College Station, Tex).

Figure 1 compares the observed trends in expenditures for ambulatory and inpatient care in Taiwan with the predicted trends estimated by the ARIMA model that assumes the absence of the SARS epidemic. During the epidemic, the figure shows significant reductions in observed expenditures compared with those expected. The general patterns for both ambulatory and inpatient services were quite similar and corresponded to each transition period of the SARS epidemic. Correspondingly, virtually no impact was observed before the first hospital cluster in late April, when the epidemic was effectively contained. A significant reduction was observed in May and continued to expand significantly in June, when the fears of SARS grew after the expansion of the epidemic to all of Taiwan. Finally, the expenditures increased gradually in July and August after the SARS epidemic was over. Compared with ambulatory care, inpatient care experienced larger reductions in expenditure at the peak period and rebounded to levels closer to usual values toward the end of the epidemic. This suggests that the SARS epidemic had a stronger influence on inpatient services than on ambulatory services.

Although the responses of medical service expenditures were similar to those of medical service utilization, reductions in utilization were relatively larger. Inpatient services experienced the largest reduction (35.2%), followed by dental services (23.9%) and Western medicine ambulatory services (16.7%) at the peak of the SARS epidemic (Table 1). On the other hand, unlike other types of medical services, Chinese medicine services experienced an increase in utilization (1.8%) during the SARS epidemic. One plausible explanation may be that Chinese medicine services served as a substitute for Western medicine ambulatory services.

Over the study period, we observed significant utilization reductions at the peak of the SARS epidemic. Overall, this short-term impact on utilization reductions translated into an approximate $18.8 billion new Taiwan dollars decrease (approximately 6% of the annual National Health Insurance expenditure) in health care expenditure during the SARS epidemic from April 2003 through August 2003. The results strongly suggest that the fears of SARS significantly influenced people’s care-seeking behavior and that this fear seriously compromised their accessibility to quality care.

Although all the international attention is focused on the direct causes of SARS, serious health consequences resulting from people’s fears of SARS should not be overlooked. The results presented here could provide public health agencies with a more complete picture of overall health impacts of the SARS epidemic, so that when SARS re-emerges, it can guide public health officials to prevent avoidable health consequences because of the fears people have regarding SARS.

Table
TABLE 1— Observed and Predicted Monthly Medical Expenditures and Utilizations, by Type of Medical Service: Taiwan, January 2003 through August 2003
TABLE 1— Observed and Predicted Monthly Medical Expenditures and Utilizations, by Type of Medical Service: Taiwan, January 2003 through August 2003
 Pre-SARS and Initial SARS PeriodPeak SARS PeriodPost-SARS Period
 Jan–Mar, Avg $/No.April, $/No.Difference, %May, $/No.Difference, %June, $/No.Difference, %July, $/No.Difference, %August, $/No.Difference, %
Expenditures
Inpatient care
    Observed10 14310 8450.18808−21.97888−26.510 228−11.310 334−8.3
    Expected10 26910 839 11 278 10 729 11 533 11 272 
Ambulatory care
    Observed17 13117 161−2.515 726−14.713 922−18.116 503−10.616 226−7.9
    Expected16 97717 601 18 427 17 006 18 467 17 623 
Dental care
    Observed22972339−9.11991−23.52083−16.32538−7.22495−2.8
    Expected23232572 2603 2488 2736 2568 
Chinese medicine
    Observed134314580.81418−8.31331−1.41454−4.714502.0
    Expected13621446 1546 1351 1525 1421 
Utilization
Inpatient care
    Observed241245−6.3180−32.4167−35.2227−16.8228−15.7
    Expected245262 266 258 272 271 
Ambulatory care
    Observed23 11722 5251.318 665−22.215 744−23.918 668−18.119 043−11.1
    Expected22 32322 245 23 979 20 692 22 783 21 418 
Dental care
    Observed20402055−9.71717−25.31833−16.72269−5.62231−1.4
    Expected20732275 2299 2201 2404 2262 
Chinese medicine
    Observed245426545.42558−5.823591.82575−1.426067.2
    Expected24302519 2715 2319 2612 2431 

Note. Avg = monthly average; $ = new Taiwan dollars in millions; No. = number of visits per admissions in thousands; Difference = [(observed value − predicted value)/predicted value] 100. The official exchange rate for 2003 published by the Central Bank of China is 1 US$ = 34.24 New Taiwan $. Available at: http://www.cbc.gov.tw. Accessed February 26, 2004.

We thank Roger Haesevoets for editing the brief.

Human Participant Protection No protocol approval was needed for this study.

References

1. Guan Y, Zheng BJ, He YQ, et al. Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China. Science. 2003;302:276–278. Crossref, MedlineGoogle Scholar
2. Cinatl J, Morgenstern B, Bauer G, et al. Treatment of SARS with human interferons. Lancet. 2003;362:293–294. Crossref, MedlineGoogle Scholar
3. Kuiken T, Fouchier RA, Schutten M, et al. Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome. Lancet. 2003;362:263–270. Crossref, MedlineGoogle Scholar
4. Donnelly CA, Ghani AC, Leung GM, et al. Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong. Lancet. 2003;361:1761–1766. Crossref, MedlineGoogle Scholar
5. Lipsitch M, Cohen T, Cooper B, et al. Transmission dynamics and control of severe acute respiratory syndrome. Science. 2003;300:1966–1970. Crossref, MedlineGoogle Scholar
6. Emanuel EJ. The lessons of SARS. Ann Intern Med. 2003;139:589–591. Crossref, MedlineGoogle Scholar
7. Haines CJ, Chu YW, Chung TK. The effect of severe acute respiratory syndrome on a hospital obstetrics and gynaecology service. BJOG. 2003;110:643–645. Crossref, MedlineGoogle Scholar
8. Clark J. Fear of SARS thwarts medical education in Toronto. BMJ. 2003;326:784. Crossref, MedlineGoogle Scholar
9. Yeoh SC, Lee E, Lee BW, et al. Severe acute respiratory syndrome: private hospital in Singapore took effective control measures. BMJ. 2003;326:1394. Crossref, MedlineGoogle Scholar
10. Maunder R, Hunter J, Vincent L, et al. The immediate psychological and occupational impact of the 2003 SARS outbreak in a teaching hospital. CMAJ. 2003;168:1245–1251. MedlineGoogle Scholar
11. Centers for Disease Control and Prevention. Severe acute respiratory syndrome—Taiwan, 2003. JAMA. 2003;289:2930–2932. Crossref, MedlineGoogle Scholar
12. Chien LC, Yeh WB, Chang HT. Lessons from Taiwan. CMAJ. 2003;169:277. MedlineGoogle Scholar
13. Box GEP, Jenkins GM. Time Series Analysis Forecasting and Control. San Francisco, Calif: Holden-Day; 1976. Google Scholar

Related

No related items

TOOLS

SHARE

ARTICLE CITATION

Hong-Jen Chang, MD, MPH, Nicole Huang, MPH, Cheng-Hua Lee, MD, DrPH, Yea-Jen Hsu, MS, Chi-Jeng Hsieh, MS, and Yiing-Jenq Chou, MD, PhD Hong-Je Chang, Cheng-Hua Lee, and Chi-Jeng Hsieh are with the Bureau of National Health Insurance, Taipei, Taiwan. Nicole Huang is with the Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, Md. Yea-Jen Hsu and Yiing-Jenq Chou are with the Department of Social Medicine, School of Medicine, National Yang Ming University, Taipei, Taiwan. “The Impact of the SARS Epidemic on the Utilization of Medical Services: SARS and the Fear of SARS”, American Journal of Public Health 94, no. 4 (April 1, 2004): pp. 562-564.

https://doi.org/10.2105/AJPH.94.4.562

PMID: 15054005